Clinical trial

Tubular Markers in Response to Saxagliptin Therapy

NCT04521049

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-03-01

PhasePHASE4

Study timeline

Study start (actual)2019-03-01Date precision: day

Registry last updated2020-08-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

Saxagliptin 5mgDRUG

Sponsors & collaborators

Beni-Suef Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04521049 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.